In this study, for the first time we investigated the expression of CD44 and CD133 in a large panel of human colorectal tumour cell lines and determine association to sensitivity to treatment with anti-HER inhibitors and cytotoxic drugs. This evidence concerns the gene PROM1 and colorectal neoplasm.